Polsinelli recently advised InfuCare Rx, one of the nation’s largest independent providers of specialty infusion services, on a recapitalization of the business through a strategic founder-led equity buyback.

This transaction underscores InfuCare Rx management’s long-term commitment to the firm’s vision and values. More information can be found here.

The Polsinelli team involved in this transaction was led by Shareholders Nipun J. Patel and Craig Circosta. The team was further supported by Tax Chair William J. Sanders and Shareholders Michael Dolan, Seth M. Aigner, Rachel L. Tenin and Nicole F. Martini, as well as Associates Maira Huizar, Matthew Rubino and Michael Romeo.